Patent details

Herbas

VPB

Print

EN | LT

LT - NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV

EN - NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07H 19/10
		A61K 31/7072
		A61P 31/14

European patent
(11)	Number of the document	2940031
(13)	Kind of document	T
(96)	European patent application number	14760567.9
	Date of filing the European patent application	2014-03-06
(97)	Date of publication of the European application	2015-11-04
(45)	Date of publication and mention of the grant of the patent	2017-09-27
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/CN2014/073004
	Date	2014-03-06

PCT application publication
(87)	Number	WO 2014/135107
	Date	2014-09-12

Priority applications
(30)	Number	Date	Country code
	201310075423	2013-03-08	CN

Inventors
(72)	WANG, Yong, CN ZHAO, Liwen, CN ZHANG, Xian, CN BI, Sheng, CN GAO, Yiping, CN CHEN, Hongyan, CN WANG, Dezhong, CN NAN, Yang, CN ZHANG, Cang, CN LI, Yuxiu, CN ZHANG, Di, CN

Grantee
(73)	Nanjing Sanhome Pharmaceutical Co., Ltd., Nanjing Economic and Technological Development Zone No. 9 Huizhong Road, Nanjing Jiangsu 210038, CN

Title
(54)	NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV
	NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV